Invests in GMP manufacturing
Boston, United States · AUM $3.5B
100focus
BiologicsCell & gene therapyDiagnostics
FDAEMAMHRAPMDA
PORT 246 companies$25M–$100M
Loading…
Capital & Advisory
Investors & VC
Venture, PE & strategic capital5
firms listed
Venture capital, private equity and strategic investors — matched to your modality, stage and geography.
Scores are deterministic, rules-based — not AI.
Rare diseaseOncologyImmunology
EMAMHRAFDAICH guidelines
PORT 205 companies$5M–$25M
Infectious diseaseOncologyRare disease
FDAEMAICH guidelinesEU GMP Annex 1
PORT 205 companies$25M–$100M
OncologyRare diseaseCardiometabolicInfectious disease
FDAEMAICH guidelines
PORT 205 companies$25M–$100M